Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small...
The positive CHMP opinion is based on results from the Phase II PHAROS trial, which demonstrated an objective response rate (ORR) of 75%...
CORRECTION FROM SOURCE: Doubleview Reports Maiden Mineral Resource Estimate
Resource estimate highlights: Indicated resource estimate of 150 million tonnes (Mt) and inferred resource estimate of 477 Mt at 0.2% copper equivalent ("CuEq")...
AGW-MS Capital: Launching Fixed Income ETF Products to Lead the Investment Trend
DENVER, USA - Media OutReach Newswire - 26 July 2024 - AGW-MS Capital is customer-centric, focusing on providing comprehensive and professional investment...
2024 FIABCI-Taiwan Real Estate Excellence Awards Ceremony Focus on Promoting ESG Principles and Sustainable Developments in Taiwan
TAIPEI, TAIWAN - Media OutReach Newswire - 26 July 2024 - The 2024 FIABCI-Taiwan Real Estate Excellence Awards, held on the evening...
Azazie Unveils Fashion Forward Atelier Collection – "Secret Garden"
LOS ANGELES, July 26, 2024 /PRNewswire/ -- Azazie, the leading DTC e-tailer for all things bridal and occasion wear, is thrilled to announce the...
ReviR Therapeutics Raises $30 Million Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders
BRISBANE, Calif., July 26, 2024 /PRNewswire/ -- ReviR Therapeutics, an AI-enabled biotechnology company focused on developing small molecule RNA modulators for neurogenetic diseases, announced...
